Sakura Study

Dr. Pauline Merrill and her research team were announced as the #1 recruiting site in the world(out of 149 eligible sites!) for the SAKURA study.

The SAKURA study is a A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study for the Treatment of Active, Non-Infectious Uveitis.  Uveitis is swelling of the middle later of the eye, which is called the “uvea”.  Uveitis is a rare condition and it is classified based on the location of the inflammation.  Phase III will evaluate the investigational drug sirolimus for the treatment of non infectious posterior uveitis.

Posted in: News and Events


COVID-19/CORONAVIRUS UPDATE

Patient safety is our top priority. If you are having flu-like symptoms, fever, cough, chills, shortness of breath please DO NOT VISIT US at this time and contact your local health provider.

To ensure your health is protected, we are limiting the number of people in our offices. We are asking that ONLY PATIENTS enter our office. Visitors and/or support persons should remain in the car or other location. If the visitor or support person must be present, screening questions will be asked and if positive responses are received the visitor/ support person will not be allowed in the office.

We appreciate your cooperation and understanding.

For ongoing updates and recommendations, please visit the following websites: Centers For Disease Control (cdc.gov), American Academy of Ophthalmology (aao.org), World Health Organization (who.int)